A study published in the journal eLife of 81 semi-supercentenarians—people 105 years of age or older—and supercentenarians—110 years or older from across Italy, were analyzed by researchers from the University of Bologna, Italy and Nestle Research in Lausanne, Switzerland. Researchers compared genetic data from these extraordinary agers to 36 healthy people from the same region whose age, on average, was 68 years.
First-time marathon runners can add years to their lives and reap the health rewards of lower blood pressure and healthier arteries, even if they take on the challenge in mid-to-later life, research showed.
People who get even a small amount of exercise may be less likely to die prematurely than their more sedentary counterparts, a research review suggests.
There has been a heightened interest in longevity research. Some have noted that older billionaires such as Bill Gates, Michael Bloomberg, Richard Branson and others have been investing heavily into biopharma companies focused on aging and aging-related diseases.
Two leading longevity biotechnology companies, Elevian and Insilico Medicine, announced a research and development partnership to develop oral medications targeting the GDF11 pathway and associated targets.